- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Halozyme Therapeutics Inc
+ Add to WatchlistHALO:US
7.3900 USD 0.0600 0.81%As of 10:16:40 ET on 05/24/2013.
Company Profile for Halozyme Therapeutics Inc (HALO)
Halozyme Therapeutics, Inc. is a biopharmaceutical company developing products for the diabetes, cancer, dermatology and drug delivery markets. The Company's platform technology is based on recombinant human hyaluronidase plus additional enzymes. Halozyme applies its technology to its proprietary programs and to partnerships with pharmaceutical companies.
Contact Information
Halozyme Therapeutics Inc
11388 Sorrento Valley Road
San Diego, CA 92121
United States
Key Executives for Halozyme Therapeutics Inc (HALO)
| Gregory Ian Frost "Greg"President/CEO/Co-Founder | David A RamsayChief Financial Officer |
| James P ShafferVP/Chief Commercial Officer | H Michael Shepard "Mike"VP/Chief Scientific Officer |
| Jean I LiuVP/Secretary/General Counsel |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Rate this Page